chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a RN concerning a 10 year old female who on 06Nov1998 was vaccinated with a dose of varicella virus vaccine live. On 16Mar05 the pt presented to the physician with chickenpox characterized by a vesicular rash of over 100 lesions, headache, and a fever of 102F. She was treated with OTC diphenhydramine hydrochloride (Benadryl), acetaminophen (Tylenol) and calamine lotion. At the time of this report the pt was recovering. No product quality complaint was involved. Additional information has been requested.
Patient checked in, mom states Moderna was first vaccine given, THOR was not checked. This nurse assumed that vaccine were double checked because those in charge said that there were only two moderna vaccines that day. I roomed patients, went over check list , it stated they had Moderna vaccine. I gave the vaccine, checked the vaccine card and noted the error. Patients were asked to wait for 1/2 hour prior to leaving and a follow up telephone call was made later.
Positive COVID-19 test with symptoms; Elbows and hands broke out in hives; Urticaria and flu like symptoms were getting worse each day; Patient woke up in sweat puddles but no fever; This is a spontaneous report from a contactable consumer (patient).   A 24-year-old non-pregnant female patient received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Lot. EL09265) in the left arm, at single dose, on 03Feb2021 at 10:00 AM, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. Past drug event included hives due to ondansetron hydrochloride (ZOFRAN). The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine and she had not received any other medications within 2 weeks prior to the BNT162B2. On 04Feb2021, at 06:00, the patient experienced flu like symptoms, a lot of mucus in cough, she woke up in sweat puddles but no fever. Chills, body aches and elbows and hands broke out in hives. Urticaria and flu like symptoms were getting worse each day. Emergency Room Visit / Physician Office Visit required. Treatment was received. Post the vaccination, the patient has been tested for COVID-19 (Nasal Swab, POCT rapid screening) and resulted positive on 06Feb2021. Clinical outcome of COVID-19 was unknown, while the patient did not recover from the other events.
Chills, fatigue, sore arm -- lasted one day on the day after the shot.
jabbing pain; had a shingles episode after first dose; Tingling to the left scapula; This case was reported by a physician via call center representative and described the occurrence of shingles in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th October 2020, the patient received the 1st dose of Shingrix. On 16th October 2020, 4 days after receiving Shingrix, the patient experienced shingles and tingling. On 17th October 2020, the patient experienced pain. The patient was treated with valaciclovir hydrochloride (Valtrex). On 21st October 2020, the outcome of the pain was recovered/resolved. On 30th November 2020, the outcome of the tingling was recovered/resolved. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles, tingling and pain to be related to Shingrix.  Additional details were provided as follows: The experienced shingles after receiving the 1st dose of Shingrix. The patient started to have tingling sensation on the left scapula on 16th October 2020.  From 17th October 2020 to 21st October 2020, the patient presented jabbing pain instead of tingling and on 22nd October 2020 patient went to the physician, reporter, and physician diagnosed patient with shingles and prescribed Valtrex 1 gram every 8 hours for 7 days. According to reporter, shingles symptoms had abated by time of the report. The reporter consented to follow up.
Pt recvd 2nd dose of Engerix-B 17MAY91 & reporter indicated that due to exposure a titer was taken p/2nd dose & it was determined that the pt had a low titer of 0.9; 3rd dose of Engerix-B was administered & titer results are awaited;
Sudden extreme swollen lymph under jaw, side neck and base of  skull, and left arm pit. Intermittent Numbness follows same path from injection to elbow through forearm to thumb. New Slight redness and heat at injection site.   Mild throat irritation and drainage (I suspect from wildfire smoke, but could be related to lymph, so including.)
Pt administered varicella (subq) L arm, Tdap in L deltoid, MENACTRA (R deltoid) Hep A (R deltoid) on 9/8/09. Presented with erythematous 6cm x 3 1/2 area @ varicella administration site.
Two months after completing the second Moderna vaccine, my menstrual cycle has changed.  In May, my cycle was extremely lighter than normal. In June, I experienced passing of 1 large blood clot daily  with no menstrual flow from June 1 to June 16.  From June 17 to June 24, I've experienced a heavier than normal flow with the passing of multiple large clots throughout the day. From June 25 to current, I have no more clots but still have a menstrual flow. The gynecologist commented that it could be a side effect of the vaccine or my fibroids. I have had my fibroids for over 15 years and my fibroid symptoms took place while in my twenties. No treatment was suggested. Simply wait and see.
Patient report a rash that developed significantly long after receiving her covid vaccine on 12/29. She reported the development of the rash on 1/8 and described it as warm to touch as well as 4cm growing to 6cm in size. The rash contained a small node that was raised at the injection site surrounded by a rose-colored rash. patient  reported 1/11 that the rash has improved and it is barely noticeable.
No period after 64 days and counting,; no ovulation; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included alprazolam (XANAX) from unknown date and for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Feb2021 the patient experienced no period after 64 days and counting and no ovulation either. The events did not result in doctor or other healthcare professional office/clinic visit.  Therapeutic measures were not taken as the result of adverse events.  The clinical outcome of the events no period after 64 days and counting and no ovulation either were not resolved at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
symptoms start 5/31/21.  R facial droop, R blurred vision, inability to close R eye.  Presented with irretractable n/v, dyspagia, and obstipation on 5/27/21.
Patient received her first dose of Moderna Covid 19 Vaccine. Immediately developed hives and urticaria of upper arms.  Patient had no history of allergies or known reactions. Patient was  immediately assessed by nursing staff present.  Patient given 50 mg Benadryl PO and RRT called.  Prior to RRT arrival, patient complained of throat tightening, itching of tongue.  Patient given epi injector IM by RN.   RRT team arrived, no further treatment provided in this area. Patient moved to ED via wheelchair under nursing care.
24 hours of fever, chills, joint aches, and a mild headache. Treated with Tylenol and stayed hydrated.
Patient called on 3/29/2021 at around 2:00pm stating he is experiencing the symptoms he experienced on 3/20/21 after receiving Janssen Covid vaccine. The symptoms included: cold sweats, nausea, fever, headache, and muscle aches. He had all of these symptoms right away after receiving the vaccine, it went away and then symptoms came back 1 week later 3/29/21.  Per patient, the symptoms are manageable and does not need medical doctor attention. Advised patient if symptoms persists or come back again, he should contact his medical doctor to be seen. Also told patient to call us if symptoms does not go away or come back as well for us to report again. Told patient there is a 2 weeks time frame for immunity to kick in so symptoms could happen again.  Recommended Tylenol for fever and pain as home self treatment in the meantime.
Client seen for COVID-19 Pfizer vaccine, RN inadvertently gave Janssen & Janssen  and not 3rd booster of Pfizer COVID-19 vaccine.  Client had no adverse reaction or signs/symptoms of adverse reaction.
Tiredness, weakness, achy, severe weakness, sweating and hospitalized on 10/26/01 through 10/28/01. Similar occurrence approx. 2/3/00. Tires easily and cannot drive a distance and had blurred vision. Symptoms began on 6/15/00. The 60 day follow-up states that the pt is very tired and weka; pain in joints; hard walking and bending legs; cannot drive far (tires out). The follow-up states additional symptoms; severe cramps and pain in legs, arms, etc. The annual follow up received on 6/19/02 states tiredness, weakness, achy joints, muscles, severe weakness and sweating, blurred vision, cannot drive far, severe cramps, short memeory los (very weak and tired). Searching for anther doctors for help.
allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction). At the time of the report, HYPERSENSITIVITY (allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided by the reporter.  Treatment information was not reported.
This spontaneous report was received from a 74 year old female patient concerning herself. The patient s concurrent condition included allergies (unspecified) and drug allergies to penicillin, atropine sulfate, Hyoscyamine sulfate, Phenobarbital, DONNATAL, OMNICEF, LEVAQUIN, NEURONTIN, SULFA, SPRIVA and ASMANEX. On 05-SEP-2012 the patient was vaccinated with PNEUMOVAX 23 IM (injection site not mentioned). On the same day the patient also received AFLURIA (injection site not mentioned). Concomitant medications included omeprazole, estrogens (unspecified) and terbinafine. On 05-SEP-2012, after getting PNEUMOVAX 23 and AFLURIA. The patient experienced extreme pain and itching in her arm and she could not moved her arm. Her whole arm down to the elbow turned red. The patient sought medical attention by phone call and office visit. No lab test performed. She received treatment with ice packs and BENADRYL and prednisone. At the time of reporting, the patient was recovering from the events. Additional information has been requested.
Additional information included PREVNAR lot number, outcome, recovery date and test results. Information regarding PREVNAR was received from a healthcare professional regarding a 12-month-old female patient who experienced wide spread rash described as red, raised and pimple like on trunk and face and fever. At 12 months of age, the patient received the fourth dose on 22-Jun-2009. The patient also received the first dose of HAVRIX (Smith Kline Beecham) on 22-Jun-2009. On 23-Jun-2009 within 24 hours after being administered the vaccine, the patient experienced wide spread rash described as red, raised and pimple like on trunk and face and fever of 104 deg. F. Treatment included MOTRIN and TYLENOL for the fever. The patient has recovered. No additional information was available at the time of this report.
This spontaneous report as received from a medical assistant refers to a 15 year old patient of unknown gender. The concurrent conditions, drug reactions/allergies and medical history of the patient were not reported. On 30-NOV-2016, the patient was vaccinated with a dose of improperly stored VAQTA with lot number M027879 and expiration date of 24-JAN-2018 (strength, dose, route of administration and anatomical location were unknown) for prophylaxis, which was stored at 1.1 Celsius degrees (°C) for 27 minutes, 0.7 °C for 19 minutes, 1.1 °C for 36 minutes, 0.7 °C for 29 minutes, 1.3 °C for 17 minutes, 1.1 °C for 20 minutes, 0.9 °C for 26 minutes, 0.7 °C for 31 minutes and 1.2 °C for 24 minutes. There was no previous temperature excursion. Moreover, the temperature excursions were detected by a data logger. No concomitant therapies nor adverse effects were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA007921: US-009507513-1701USA007910:US-009507513-1701USA004148: US-009507513-1701USA003168: Original Case : 1701USA003168 US-009507513-1701USA007912: Original Case : 1701USA003168 US-009507513-1701USA007922: US-009507513-1701USA007881: US-009507513-1701USA007913: US-009507513-1701USA007882: US-009507513-1701USA004150: US-009507513-1701USA007958: US-009507513-1701USA007906: US-009507513-1701USA007895: US-009507513-1701USA007923: US-009507513-1701USA004152: US-009507513-1701USA007883: US-009507513-1701USA007897: US-009507513-1701USA007905: US-009507513-1701USA007884: US-009507513-1701USA007924: US-009507513-1701USA007925: US-009507513-1701USA007847: US-009507513-1701USA007885: US-009507513-1701USA007908: US-009507513-1701USA007909: US-009507513-1701USA007898: US-009507513-1701USA007914: US-009507513-1701USA007915: US-009507513-1701USA007916: US-009507513-1701USA007848: US-009507513-1701USA007849:
Mouth watering, body aches, fever, chills, headache, fever blister on mouth( 2 days later) sweats, achey rib area
High blood pressure, prescription given was Losartin 50 mg,  raised mg to 100mg Now under control.
Patient was given 0.5 ml's instead of 0.25 ml's for 4th dose
Knot at injection site, painful to touch, warm to touch, patient has tried warm compresses to help with discomfort. Some itching at site of reaction, but tolerable (patient not scratching or using hydrocortisone at location).
PUFFY LYMPH NODES UNDER ARM; SWOLLEN AT INJECTION SITEX; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's past medical history included level 1 endometrial cancer, and concurrent conditions included bee allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 13:30 for prophylactic vaccination. Concomitant medications included sertraline. On 08-APR-2021, the subject experienced swollen at injection site. On 10-APR-2021, the subject experienced puffy lymph nodes under arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from swollen at injection site, and puffy lymph nodes under arm. This report was non-serious.
Nausea; Fatigue; Vaccination exposure during pregnancy; Pain at injection site left arm; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy), VACCINATION SITE PAIN (Pain at injection site left arm), NAUSEA (Nausea) and FATIGUE (Fatigue) in a 34-year-old female patient (gravida 4, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025I20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (occasionally before pregnancy) and Cigarette smoker (prior use - 1 pack/ day). Concurrent medical conditions included Drug allergy (allergy to imitrex), Peanut allergy (Migraine) and Asthma (illness induced). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 26-Dec-2020 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Oct-2021. On 26-Dec-2020, the patient experienced EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy). 26-Dec-2020, the patient experienced VACCINATION SITE PAIN (Pain at injection site left arm). On 26-Dec-2020 at 6:00 PM, the patient experienced FATIGUE (Fatigue). On 26-Dec-2020 at 11:00 PM, the patient experienced NAUSEA (Nausea). On 27-Dec-2020, VACCINATION SITE PAIN (Pain at injection site left arm), NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. On 20-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccination exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient last menstrual period was on 29-DEC-2020.  Patient got pregnant in between 1st & 2nd dose about 4-10 days after conception.  On an unknown date, patient went for 6 week ultrasound, blood work, 12 week ultra sound & anatomy scan with test results being normal for all the tests.  No treatment medication was provided   This case was linked to US-MODERNATX, INC.-MOD-2021-109434 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow-up received on 28-JUL-2021. Is significant. Demographic details, pregnancy information, medical history , lab tests & Concomitant medication was added.
Information has been received from a pharmacist concerning a female (age not reported) who on an unspecified date was vaccinated with a dose of Gardasil. The pharmacist reported that the patient developed hives after receiving the vaccine and went to the emergency room because 3 months later she still had hives. The patient was not admitted to the hospital. The patient's status was reported as unknown. Additional information has been requested.
days post vaccination, at the site, were somewhat tender and indurated; localized, pruritic skin reactions at the site; 2-3 days post vaccination, at the site, were somewhat tender and indurated initially; Initial information received from United States on 21-Apr-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 18 years old and unknown gender patient who experienced localized, pruritic skin reactions at the site, days post vaccination, at the site, were somewhat tender and indurated and 2-3 days post vaccination, at the site, were somewhat tender and indurated initially  after receiving vaccine Yellow Fever Vaccine - Us [Yf-Vax].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Yellow Fever Vaccine - US (lot number, expiry date: not reported) via subcutaneous route in unknown administration site (form strength: unknown) for prophylactic vaccination. (immunization).  On an unknown date the patient developed a non-serious event of localized, pruritic skin reactions at the site (vaccination site pruritus), days post vaccination, at the site, were somewhat tender and indurated (vaccination site pain) and days post vaccination, at the site, were somewhat tender and indurated (vaccination site pain) latency unknown following the administration of Yellow Fever Vaccine - US.  It was reported, "This information localized, pruritic skin reactions at the site of SQ Yellow Fever vaccine injection The 3 individuals were 17,18, and 49 years old. They began 2-3 days post vaccination, at the site, were somewhat tender and indurated initially, but quickly became intensely pruritic while expanding This case is created for 18 year old patient.".  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was unknown for the events.; Sender's Comments:  US-SA-2023SA129044:
Blurry while driving to OBS/nausea, sweating, woozy, dizzy, pale.  Drank water. Paramedics to VS.  Felt better.  Drove home.
This spontaneous case was reported by a consumer and describes the occurrence of DRUG INEFFECTIVE (Vaccine doesn't work) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Transplant. Concurrent medical conditions included Immunosuppression (Immune suppression because of the transplant). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DRUG INEFFECTIVE (Vaccine doesn't work). At the time of the report, DRUG INEFFECTIVE (Vaccine doesn't work) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant products were not provided. Treatment medication were not reported. Company Comment: Very limited information regarding the events has been provided at this time. Further information is expected. Sender's Comments: Very limited information regarding the events has been provided at this time. Further information is expected.
vial was initially stored in the refrigerator 26-Jan-2022; 7 patients received a Moderna vaccine past the 30 day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (7 patients received a Moderna vaccine past the 30 day use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator 26-Jan-2022) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (7 patients received a Moderna vaccine past the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator 26-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (7 patients received a Moderna vaccine past the 30 day use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator 26-Jan-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment medication was provided by reporter.
Rash started on my neck and chest.  Hives spread over entire body for the next two weeks.  Dermatologist prescribed cream.
Approximately 12 hours after injection, experienced high fever, extreme shaking, chills, and body aches.  Low-grade fever (100.7) and fatigue persisted for 3 days.  Approximately two weeks later, I woke up with tinnitus and minor hearing loss in my right ear which has persisted without change to this day.
body aches in an ascending fashion, lower extremities torso then head, nausea, abd cramps, diarrhea, low grade temp;
About a week later I started having a runny nose and I was sick with flu-like symptoms and now i have a continuous headache now with the runny nose still. I have taken Tylenol Cold.
HEADACHES, BAD BODY ACHE, CHILLS, COUGH, SOB